$RVMD insider trading

Over the last 12 months, Revolution Medicines insiders reported no purchases and 10 sales totaling $25.0M across SEC Form 4 filings. 90% of the activity was filed under pre-arranged 10b5-1 trading plans.

$25.0M
10
7
90%
Side
$100K$1.0M$10M$100MMay '26JunJulAug
Mancini Anthony
Anders Jack
Horn Margaret A
Cislini Jeff
Kelsey Stephen Michael

All insider trades

Jun 29, 2026Patel Sushil▼ Sale5,580$187.99$1.0M-20.5%
Jun 24, 2026Anders Jack▼ Sale20,000$168.33$3.4M-14%
Jun 17, 2026Horn Margaret A▼ Sale93,575$160$15.0M-37.7%
Jun 16, 2026Anders Jack▼ Sale2,722$156.12$425K-2.2%
Jun 16, 2026Kelsey Stephen Michael▼ Sale4,175$156.12$652K-1.4%
Jun 16, 2026Mancini Anthony▼ Sale4,615$156.12$720K-8.5%
Jun 16, 2026GOLDSMITH MARK A▼ Sale10,020$156.12$1.6M-3.6%
Jun 16, 2026Cislini Jeff▼ Sale2,157$156.12$337K-3.7%
Jun 11, 2026Horn Margaret A▼ Sale10,000$148.01$1.5M-5.9%
May 26, 2026Mancini Anthony▼ Sale3,121$153.99$481K-5.4%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $RVMD feed.

RVMD Insider Trading — Form 4 Buys & Sells | alphai